2 unknown. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Unknown 2 |
Follow Chronic Symptomatic Functional Tricuspid Regurgitation: new trials by email Literature Review of Chronic Symptomatic Functional Tricuspid Regurgitation trials Research Report on Chronic Symptomatic Functional Tricuspid Regurgitation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) - Chronic Symptomatic Functional Tricuspid Regurgitation, Tricuspid Valve Insufficiency | Not applicable | Unknown | Mitralign, Inc. | 60 | 2017-05-22 | 2018-02-07 |
| Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™. Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) - Chronic Symptomatic Functional Tricuspid Regurgitation, Tricuspid Valve Insufficiency | Not applicable | Unknown | Mitralign, Inc. | 30 | 2015-11-01 | 2017-10-27 |
Heart Valve Diseases (2) · Tricuspid Valve Insufficiency (2)
Cardiovascular Diseases (2) · Heart Diseases (2)
Mitralign, Inc. (2)
Germany (1) · Italy (1) · Netherlands (1) · Portugal (1) · United States (1)
Christopher Meduri, MD, MPH (1) · Rebecca Hahn, MD (1)